Patent · US Active

Modified polynucleotides

US10501512B2 · kind B2 · utility

8Cited by

357References

10Claims

0Family size

Assignee

ModernaTX, Inc. · US

Inventors

Antonin de Fougerolles · Waterloo, BE
Justin Guild · Framingham, US

Key dates

Filing date	Mar 9, 2013
Grant date	Dec 10, 2019
Priority date	—
Expiry date	Mar 9, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Y304/21022
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotides, primary transcripts and mmRNA molecules.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.